Conatus Pharmaceuticals Soars 40% Ahead Of Emricasan Results
January 05, 2015 at 10:07 AM EST
Shares of Conatus Pharmaceuticals Inc (NASDAQ: CNAT) soared approximately 40 percent on Monday following an upcoming announcement on ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.